QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
Press Release
Read More
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
Literature
Read More
NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018
Press Release
Read More
Clinicopathologic Characteristics and Novel Biomarkers of Aggressive B-Cell Lymphomas in the Nasopharynx
Literature
Read More
NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier
Press Release
Read More